Blar i Department of Clinical Medicine på forfatter "Owe, Jone Furulund"

Viser treff 1-4 av 4

    • Complicating autoimmune diseases in myasthenia gravis: A review 

      Nacu, Aliona; Andersen, Jintana Bunpan; Lisnic, Vitalie; Owe, Jone Furulund; Gilhus, Nils Erik (Peer reviewed; Journal article, 2015-04-27)
      Myasthenia gravis (MG) is a rare autoimmune disease of skeletal muscle endplates. MG subgroup is relevant for comorbidity, but usually not accounted for. MG patients have an increased risk for complicating autoimmune ...

    • Patient-reported outcome after treatment for definite Lyme neuroborreliosis 

      Eikeland, Randi; Ljøstad, Unn; Helgeland, Geir; Sand, Geir; Flemmen, Heidi Øyen; Bø, Margrete Halvorsen; Nordaa, Ludmila; Owe, Jone Furulund; Mygland, Åse; Lorentzen, Åslaug Rudjord (Journal article; Peer reviewed, 2020)
      Objective To chart patient‐reported outcome measures (PROMs) in Norwegian patients treated for definite neuroborreliosis (NB). Material and Methods Adult patients treated for definite NB 1–10 years earlier supplied ...

    • Repeated acetylcholine receptor antibody-concentrations and association to clinical myasthenia gravis development 

      Heldal, Anne Taraldsen; Eide, Geir Egil; Romi, Fredrik Robert; Owe, Jone Furulund; Gilhus, Nils Erik (Peer reviewed; Journal article, 2014-12-02)
      Introduction: We aimed to examine the longitudinal association between Myasthenia Gravis (MG) clinical severity and concentration of acetylcholine receptor (AChR)-antibodies to evaluate if AChR-antibody variations correlate ...

    • Total drug treatment and comorbidity in myasthenia gravis: a population-based cohort study 

      Andersen, Jintana Bunpan; Owe, Jone Furulund; Engeland, Anders; Gilhus, Nils Erik (Peer reviewed; Journal article, 2014-04-09)
      Background and purpose: Comorbidity in myasthenia gravis (MG) is important for diagnosis, treatment and prognosis. Disease complexity was assessed by examining total drug treatment, immune therapy and comorbidity in a ...